Dr Reddys Laboratories receives EIR for facility at Duvvada

Dr Reddys Laboratories receives EIR for facility at Duvvada

Feb 21, 2020 11:02 IST capital market

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from USFDA, for the companys formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).

Powered by Capital Market - Live News

Related Story